Background: Highly active antiretroviral therapy (HAART) has changed life-expectancy and mortality trends among people living with HIV/AIDS (PLWHA) since 1996. This retrospective cohort study aimed to assess the mortality epidemiology of PLWHA in Israel and analyze the causes of death.
Methods: This cohort study included all adult Israeli-citizens PLWHA between 1985 and 2010 and crossed matched with the Civil Registry to identify those who died. Death certificates were classified into AIDS or non-AIDS deaths related-causes. Standardized mortality-ratio (SMR) represented mortality excess.
Results: Of all 5140 PLWHA who were followed-up for 36 955 person-years, 1066 (20.7%) died. The ratio of AIDS-related deaths to non-AIDS related deaths reduced from 1.2:1 before 1996 to 0.6:1 after 1997, and case-fatality rates reduced from 12.0 to 0.9%, respectively (P < 0.001). SMR were 3.0 (95% CI: 2.3-3.5) for males and 3.9 (95% CI: 3.3-4.5) for females. Fatality cases were more likely older Israeli-born males, co-infected with tuberculosis, reported before 1996 and acquired HIV by drug-injection or infected-blood products. Deaths of AIDS-related causes were common among Israeli-born gay men, while non-AIDS deaths were common among those reported after 1997 and drug users.
Conclusions: Death rates declined since HAART introduction. Yet, SMR remained high, and PLWHA infected by drug-use or blood-products have not enjoyed relative longevity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896593 | PMC |
| http://dx.doi.org/10.1093/pubmed/fdx039 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIV.
J Acquir Immune Defic Syndr
August 2024
Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Background: The effect of initial antiretroviral therapy (ART) class on cancer risk in people with HIV (PWH) remains unclear.
Setting: Cohort study of 36,322 PWH enrolled (1996-2014) in the North American AIDS Cohort Collaboration on Research and Design.
Methods: We followed individuals from ART initiation (protease inhibitor [PI]-, non-nucleoside reverse transcriptase inhibitor [NNRTI]-, or integrase strand transfer inhibitor [INSTI]-based) until incident cancer, death, loss-to-follow-up, 12/31/2014, 85 months (intention-to-treat analyses [ITT]), or 30 months (per-protocol [PP] analyses).
Disseminated Combined and Bloodstream Infection Presenting as Gastrointestinal Perforation in a Patient with CARD9 Gene Mutation.
Infect Drug Resist
October 2024
Department of Laboratory Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, People's Republic of China.
This study presents a case of combined with bloodstream infection with gastrointestinal symptoms as the sole initial clinical manifestation.The patient is a resident of Shanghai and has no recent travel history to areas with a high risk of infection. He was admitted to the emergency room due to severe upper abdominal pain.
View Article and Find Full Text PDFExcess mortality attributable to AIDS among people living with HIV in high-income countries: a systematic review and meta-analysis.
J Int AIDS Soc
November 2024
Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.
Introduction: Identifying strategies to further reduce AIDS-related mortality requires accurate estimates of the extent to which mortality among people living with HIV (PLHIV) is due to AIDS-related or non-AIDS-related causes. Existing approaches to estimating AIDS-related mortality have quantified AIDS-related mortality as total mortality among PLHIV in excess of age- and sex-matched mortality in populations without HIV. However, recent evidence suggests that, with high antiretroviral therapy (ART) coverage, a growing proportion of excess mortality among PLHIV is non-AIDS-related.
View Article and Find Full Text PDFImpact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort.
AIDS
February 2025
Infectious Disease Clinic, Fondazione IRCCS San Gerardo dei Tintori, University of Milano Bicocca, Monza.
Article Synopsis
- The study evaluated how smoking affects major clinical events (MCEs) in people with HIV in Italy over nearly a decade.
- Researchers tracked 983 individuals, finding notable rates of cardiovascular events, cancers, and deaths, with a total MCE incidence rate of 17.6 per 1000 person-years.
- Key risk factors for increased MCEs included older age, higher nicotine dependence, low CD4+ counts, previous cancers, and using injection drugs, highlighting the serious impact of smoking on health in this population.
Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America.
Open Forum Infect Dis
July 2024
Population Health Sciences, University of Bristol, Bristol, UK.
Article Synopsis
- The study aimed to evaluate how well the Veterans Aging Cohort Study (VACS) Index 2.0 predicts specific causes of death in people with HIV (PWH) receiving antiretroviral therapy (ART), which could improve targeted healthcare interventions.
- It involved analyzing data from over 59,000 PWH who started ART between 2000 and 2018, calculating their VACS scores and examining the relationship between these scores and causes of death through various statistical models.
- Findings revealed that the VACS Index 2.0 was particularly effective at predicting deaths from AIDS-related causes and other measurable health issues, but less reliable for predicting suicides or accidental deaths.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!